<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of the myeloid markers CD13, CD33, and CD15 in two hundred and eighty-three cases of de novo childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) is examined </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of at least one marker is a frequent event which is noted in 64% and 74% of B- and T-lineage ALL cases, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Certain patterns of myeloid antigen expression can be recognized including: no expression of CD13, CD33, and CD15 in mature <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, significantly higher levels of CD13 and CD33 and significantly lower levels of CD15 in <z:chebi fb="18" ids="30182">TEL</z:chebi>-AML1-positive B cell precursor ALL, no expression of CD13 and CD33 in E2A-PBX1-positive B cell precursor ALL cases and common <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> (double positive for CD4 and CD8), and no expression of CD13 in MLL-AF4-positive B cell precursor ALL cases </plain></SENT>
<SENT sid="3" pm="."><plain>Although the numbers in some ALL subtypes are small, these patterns are consistent with nonrandom expression of myeloid markers in de novo <z:e sem="disease" ids="C0023452" disease_type="Neoplastic Process" abbrv="">childhood ALL</z:e> </plain></SENT>
</text></document>